Search results for "Anticoagulation"
Apixaban safer, more effective than rivaroxaban for afib with heart disease, study finds
Apixaban was associated with a lower rate of ischemic stroke or systemic embolism and a lower rate of bleeding in a propensity-matched cohort study of commercially insured patients with atrial fibrillation (AF) and valvular heart disease.
https://immattersacp.org/weekly/archives/2022/10/18/2.htm
18 Oct 2022
DOACs associated with lower risk of fracture than warfarin in atrial fibrillation
Patients taking apixaban, dabigatran, or rivaroxaban had lower rates of hip and vertebral fractures than those taking warfarin, with no difference seen between the direct oral anticoagulants (DOACs).
https://immattersacp.org/weekly/archives/2020/05/19/2.htm
19 May 2020
MKSAP Quiz: INR management
A 61-year-old woman undergoes routine evaluation. She reports no recent changes in her medications. She has a history of idiopathic deep venous thrombosis. Her only medication is warfarin, initiated 2 months ago. Following a physical exam and international normalized ratio (INR) measurement of 7.2, what is the most appropriate management?
https://immattersacp.org/weekly/archives/2020/07/28/3.htm
28 Jul 2020
CDC updates guidance on COVID-19, studies show vitamins don't improve outcomes
The CDC offered new guidance on immunocompromised patients and pulse oximetry's accuracy, and recent trials showed that vitamin D, zinc, and ascorbic acid didn't help COVID-19 patients but prophylactic anticoagulation did.
https://immattersacp.org/weekly/archives/2021/02/23/1.htm
23 Feb 2021
DOACs show better safety, effectiveness than warfarin in patients with valvular afib
As a class, direct oral anticoagulants (DOACs) were associated with lower risk for ischemic stroke or systemic embolism and major bleeding events than warfarin, and results were consistent for apixaban and rivaroxaban.
https://immattersacp.org/weekly/archives/2021/03/30/1.htm
30 Mar 2021
Non-vitamin K oral anticoagulants appear superior to vitamin K antagonists in early-stage CKD
An accompanying editorial said that the current review supports a superior benefit profile of non-vitamin K oral anticoagulants (NOACs) in patients with atrial fibrillation and early-stage chronic kidney disease (CKD).
https://immattersacp.org/weekly/archives/2019/07/16/2.htm
16 Jul 2019
New drugs could improve anticoagulation rates
Dabigatran and rivaroxaban spare patients the need for regular blood checks, but warfarin is less expensive and has an antidote to reverse bleeding, if needed. Does the convenience of the new generation of drugs and the potential to increase compliance with therapy outweigh their downsides?.
https://immattersacp.org/archives/2012/04/anticoagulation.htm
1 Apr 2012
AHA statement reviews efficacy, safety of CAM therapies in patients with heart failure
Potentially beneficial complementary and alternative medicine (CAM) therapies included omega-3 polyunsaturated fatty acids, coenzyme Q10, D-ribose, and L-carnitine, the American Heart Association (AHA) said.
https://immattersacp.org/weekly/archives/2022/12/13/1.htm
13 Dec 2022
Point-of-care screening did not affect diagnosis of afib in primary care, study finds
In a randomized trial at 16 primary care clinics in Massachusetts, rates of new afib diagnosis at one year were 1.72% with afib screening of older patients using a single-lead electrocardiogram versus 1.59% with usual care.
https://immattersacp.org/weekly/archives/2022/03/08/1.htm
8 Mar 2022
Latest Curbsiders podcast episode features tips in perioperative medication management
Avital Y. O’Glasser, MD, FACP, covers perioperative anticoagulation, why “bridging is dead,” aspirin, dual antiplatelet therapy, and much more.
https://immattersacp.org/weekly/archives/2019/09/24/4.htm
24 Sep 2019